| Company Name: | Merck & Company, Incorporated | | Ticker Symbol: | MRK | | | WWW Address: | www.merck.com | | CEO: | Richard T. Clark | | No. of Employees: | 55,200 | | Common Issue Type: | CS | | Business Description: | Al research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Major [more like this]Company Name: | Merck & Company Incorporated | | Ticker Symbol: | MRK | | | WWW Address: | www.schering-plough.com | | CEO: | Richard T. Clark | | No. of Employees: | 51,000 | | Common Issue Type: | CS | | Business Description: | The Company discovers, develops and manufactures pharmaceuticals for three customer markets - human prescription, animal health, and consumer.
|
| | | Industry Information: | DRUGS - Drug Manufacturers - Major [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 36.387 |  0.167 | 36.38 | 36.39 | 36.29 | 36.83 | 35.86 | 2388437 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 76,747.5 | 2,109.2 | 0.86 | 3.64 | 1.52 | 9.5 | 4.2 | 36.96 - 20.05 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 33.43 | $ | | PE Ratio - LTM | 22.9 | |
| Market Capitalisation | 54,796.8 | mil |
| Latest Shares Outstanding | 1,639.2 | mil |
| Earnings pS (EPS) | 1.07 | $ |
| Dividend pS (DPS) | 0.26 | ¢ |
| Dividend Yield | 0.8 | % |
| Dividend Payout Ratio | 24 | % |
| Revenue per Employee | 362,784 | $ |
| Effective Tax Rate | 7.1 | % |
| Float | 1,637.7 | mil |
| Float as % of Shares Outstanding | 99.9 | % |
| Foreign Sales | 12,946 | mil |
| Domestic Sales | 5,556 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 34.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 19.20 | % |
| Gross Profit Margin | 60.0 | % |
| EBITDA Margin | 6.0 | % |
| Pre-Tax Profit Margin | 15.9 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 8.4 | % |
| Return on Equity (ROE) | 24.8 | % |
| Return on Capital Invested (ROCI) | 12.3 | % |
| Current Ratio | 2.6 | |
| Leverage Ratio (Assets/Equity) | 2.9 | |
| Interest Cover | 5.4 | |
| Total Debt/Equity (Gearing Ratio) | 0.79 | |
| LT Debt/Total Capital | 38.0 | % |
| Working Capital pS | 4.93 | $ |
| Cash pS | 2.63 | $ |
| Book-Value pS | 6.34 | $ |
| Tangible Book-Value pS | 0.94 | $ |
| Cash Flow pS | 2.32 | $ |
| Free Cash Flow pS | 1.45 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 5.27 | |
| Price/Tangible Book Ratio | 35.56 | |
| Price/Cash Flow | 14.4 | |
| Price/Free Cash Flow | 23.1 | |
| P/E as % of Industry Group | 88.0 | % |
| P/E as % of Sector Segment | 126.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 0.26 |
| Current Dividend Yield | 0.8 |
| 5-Y Average Dividend Yield | 1.1 |
| Payout Ratio | 24.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 2.6 | 100 | 292,981 | 287,769 |
| 4 Weeks | 33.49 | 27.91 | 29.29 | 14.1 | 114 | 249,826 | 3,997,211 |
| 13 Weeks | 33.49 | 26.77 | 27.12 | 23.3 | 113 | 162,276 | 9,736,557 |
| 26 Weeks | 33.49 | 22.83 | 23.35 | 43.2 | 116 | 154,201 | 18,966,678 |
| 52 Weeks | 33.49 | 12.85 | 15.76 | 112.1 | 169 | 169,905 | 41,966,453 |
| YTD | 33.49 | 16.16 | - | 96.3 | 162 | 174,929 | 37,784,724 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 31.01 | 29.78 | 28.54 | 25.99 | 24.62 | 0.99 | 1.07 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 18.19 | 93.0 | 20.61 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 4.01 | 83.2 | 5.58 |
| Capital Spending | 28.82 | NA | 45.47 |
| R&D | 18.74 | NA | 18.27 |
| Normalized Inc. | 0.00 | NA | 37.34 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -4.3 | -1.7 | 45.8 |
| Earnings % | 51.4 | -12.6 | 0.0 |
| EPS % | 52.7 | -14.7 | 0.0 |
| EPS $ | 0.39 | -0.05 | 2.11 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 20.55 |
| Current Ratio | 2.1 |
| Quick Ratio (Acid Test) | 1.2 |
| Liquidity Ratio (Cash) | 0.65 |
| Receivables Turnover | 6.5 |
| Average Collection Period | 55 |
| Working Capital/Equity | 72.0 |
| Working Capital pS | 3.55 |
| Cash-Flow pS | 2.42 |
| Free Cash-Flow pS | 1.41 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.24 |
| Financial Leverage Ratio (Assets/Equity) | 3.5 |
| Debt Ratio | 62.6 |
| Total Debt/Equity (Gearing Ratio) | 1.02 |
| LT Debt/Equity | 0.99 |
| LT Debt/Capital Invested | 67.1 |
| LT Debt/Total Liabilities | 45.1 |
| Interest Cover | 4.8 |
| Interest/Capital Invested | 2.34 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 14.57 |
| Tobin's Q Ratio | 1.95 |
| Current P/E Ratio - LTM | 22.90 |
| Enterprise Value (EV)/EBITDA | 84.82 |
| Enterprise Value (EV)/Free Cash Flow | 31.68 |
| Dividend Yield | 0.8 |
| Price/Tangible Book Ratio - LTM | 35.56 |
| Price/Book Ratio - LTM | 5.27 |
| Price/Cash Flow Ratio | 14.4 |
| Price/Free Cash Flow Ratio - LTM | 23.1 |
| Price/Sales Ratio | 3.06 |
| P/E Ratio (1 month ago) - LTM | 19.7 |
| P/E Ratio (26 weeks ago) - LTM | 17.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 88.0 |
| P/E as % of Sector Segment | 126.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 20.9 |
| PER SHARE FIGURES |
| LT Debt pS | 4.88 |
| Current Liabilities pS | 3.19 |
| Tangible Book Value pS - LTM | 0.94 |
| Book Value pS - LTM | 6.34 |
| Capital Invested pS | 11.26 |
| Cash pS - LTM | 2.63 |
| Cash Flow pS - LTM | 2.32 |
| Free Cash Flow pS - LTM | 1.45 |
| Earnings pS (EPS) | 1.07 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 12.36 |
| Free Cash Flow Margin 5YEAR AVG | -19.99 |
| Net Profit Margin | 10.3 |
| Net Profit Margin - 5YEAR AVRG. | 1.5 |
| Equity Productivity | 2.30 |
| Return on Equity (ROE) | 23.7 |
| Return on Equity (ROE) - 5YEAR AVRG. | 2.5 |
| Capital Invested Productivity | 1.00 |
| Return on Capital Invested (ROCI) | 10.3 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 1.3 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 6.8 |
| Return on Assets (ROA) - 5YEAR AVRG. | 0.8 |
| Gross Profit Margin | 60.0 |
| Gross Profit Margin - 5YEAR AVRG. | 67.3 |
| EBITDA Margin - LTM | 6.0 |
| EBIT Margin - LTM | 19.5 |
| Pre-Tax Profit Margin | 11.1 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 4.4 |
| Effective Tax Rate | 7.1 |
| Effective Tax Rate - 5YEAR AVRG. | -81.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 232 |
| Revenue per Employee | 362,784 |
| Net Income per Employee | 37,314 |
| Average Collection Period | 55 |
| Receivables Turnover | 6.5 |
| Day's Inventory Turnover Ratio | 177 |
| Inventory Turnover | 2.0 |
| Inventory/Sales | 16.8 |
| Accounts Payble/Sales | 9.06 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 3.20 |
| Fixed Assets Turnover | 1.08 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 5.49 |
| Revenue per $ Plant | 2.71 |
| Revenue per $ Common Equity | 2.30 |
| Revenue per $ Capital Invested | 1.00 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 36.9 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 42.3 |
| Research & Devlopment (R&D) as % of Revenue | 19.1 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 19.1 |
|
|  
| | |  |  | |
| |